Research Article

Interferon-Gamma Release Assay Performance of Cerebrospinal Fluid and Peripheral Blood in Tuberculous Meningitis in China

Table 1

Clinical characteristics in study population ().

CharacteristicsTBM group
()
Non-TBM group
()
value

Age, median (IQR), yrs31 (23–45)27 (23–47)0.938
Gender (female/male)19/349/280.245
HIV infection020.087
Cause of diseases
 Tuberculous meningitis53NANA
 Viral meningitisNA22NA
 Purulent meningitisNA4NA
 Cryptococcal meningitisNA4NA
 Meningeal malignant tumorNA2NA
 Subarachnoid hemorrhageNA1NA
 Other causesNA4NA
Underlying diseases
 Diabetes mellitus430.922
 Viral hepatitis220.712
 SLE100.414
 Myeloma100.414
CSF profile
 Total WBC count, median cell ×103/ml (IQR)54 (20–116)15 (6.5–72)0.006
 Lymphocyte count, median cell ×103/ml (IQR)45 (19–80)12 (5.5–63)0.002
 ADA, median U/L (IQR)4.1 (1.9–6.0)2.2 (1.75–3.0)0.005
 CSF/serum glucose ratio, median ratio (IQR)0.45 (0.38–0.56)0.64 (0.50–0.70)<0.001
 Glucose, median mmol/L (IQR)2.20 (1.73–2.75)3.10 (2.80–3.65)<0.001
 Protein level, median g/L (IQR)0.75 (0.63–1.10)0.40 (0.30–0.90)0.001
 Chloride concentration, median mmol/L (IQR)117.1 (112.6–121.0)120.1 (118.5–122.0)0.003

Note. NA: not applicable; IQR: interquartile range.